Back
Status filter :


RESET SEARCH AND FILTERS
Malignant disease
Malignant disease / Antibody responsive malignancy
  amivantamab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA850
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Rybrevant (Janssen-Cilag Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  atezolizumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA525
NICE TA739
NICE TA520
NICE TA584
NICE TA705
NICE TA823
NICE TA638
NICE TA639
NICE TA666
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Tecentriq (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  avelumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA517
NICE TA691
NICE TA645
NICE TA788
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Bavencio (Merck Serono Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  bevacizumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA118
NICE TA212
NICE TA242
NICE TA178
NICE TA214
NICE TA263
NICE TA284
NICE TA285
NICE TA666
NICE TA946
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Avastin (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  blinatumomab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA450
NICE TA589
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for solution for infusion
Blincyto (Amgen Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  brentuximab vedotin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA478
NICE TA641
NICE TA524
NICE TA577
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for solution for infusion
Adcetris (Takeda UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  cemiplimab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA802
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Libtayo (Regeneron UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  cetuximab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA145
NICE TA473
NICE TA242
NICE TA439
NICE TA668
NICE does not recommend this medicine for the following indication

TA242 - Cetuximab monotherapy or combination chemotherapy is not recommended for the treatment of patients with metastatic colorectal cancer that has progressed after first-line chemotherapy.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Erbitux (Merck Serono Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  daratumumab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA763
NICE TA783
NICE TA897
NICE TA917
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for injection
Darzalex (Janssen-Cilag Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Darzalex (Janssen-Cilag Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  dinutuximab beta [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA538
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  dostarlimab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA779
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  durvalumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA798
NICE TA944
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  elotuzumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  gemtuzumab ozogamicin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA545
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for infusion
Mylotarg (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  inotuzumab ozogamicin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA541
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for infusion
Besponsa (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  ipilimumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA268
NICE TA319
NICE TA400
NICE TA716
NICE TA724
NICE TA780
NICE TA818
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Yervoy (Bristol-Myers Squibb Pharmaceuticals Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  isatuximab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA658
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Sarclisa (Sanofi) Non-formulary at HHFT and not suitable for primary care prescribing
  mogamulizumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA754
NICE TA754
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Poteligeo (Kyowa Kirin Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  nivolumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA384
NICE TA400
NICE TA684
NICE TA417
NICE TA780
NICE TA462
NICE TA655
NICE TA713
NICE TA724
NICE TA876
NICE TA530
NICE TA817
NICE TA707
NICE TA746
NICE TA857
NICE TA865
NICE TA716
NICE TA736
NICE TA818
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Opdivo (Bristol-Myers Squibb Pharmaceuticals Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  obinutuzumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA343
NICE TA513
NICE TA629
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Gazyvaro (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  panitumumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA242
NICE TA439
NICE does not recommend this medicine for the following indication

TA242 - Panitinumab monotherapy is not recommended for the treatment of patients with metastatic colorectal cancer that has progressed after first-line chemotherapy.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Vectibix (Amgen Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  pembrolizumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA357
NICE TA366
NICE TA766
NICE TA837
NICE TA428
NICE TA531
NICE TA683
NICE TA770
NICE TA692
NICE TA540
NICE TA540
NICE TA772
NICE TA650
NICE TA830
NICE TA858
NICE TA661
NICE TA709
NICE TA914
NICE TA737
NICE TA801
NICE TA851
NICE TA939
NICE TA904
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Keytruda (Merck Sharp & Dohme (UK) Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  pertuzumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA424
NICE TA509
NICE TA569
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Perjeta (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  polatuzumab vedotin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA649
NICE TA874
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for infusion
Polivy (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  ramucirumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA378
NICE TA403
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Cyramza (Eli Lilly and Company Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  rituximab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA308
NICE TA195
NICE TA243
NICE TA137
NICE TA193
NICE TA226
NICE TA174
NICE TA359
NICE TA561
Rituximab for malignancy

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

  Solution for infusion
MabThera (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Rixathon (Sandoz Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Truxima (Celltrion Healthcare UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  sacituzumab govitecan [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA819
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for infusion
Trodelvy (Gilead Sciences Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  siltuximab Non-formulary at HHFT and not suitable for primary care prescribing
  trastuzumab [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA34
NICE TA257
NICE TA509
NICE TA208
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Herceptin (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for infusion
Herceptin (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Herzuma (Celltrion Healthcare UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Kanjinti (Amgen Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Ontruzant (Organon Pharma (UK) Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Trazimera (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Zercepac (Accord-UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  trastuzumab deruxtecan [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA704
NICE TA862
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for solution for infusion
Enhertu (Daiichi Sankyo UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  trastuzumab emtansine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA458
NICE TA632
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for infusion
Kadcyla (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Malignant disease / Carcinoid syndrome
  telotristat ethyl Non-formulary at HHFT and not suitable for primary care prescribing
Malignant disease / Immunotherapy responsive malignancy
  Bacillus Calmette-Guérin [Specialist drug] Hospital only
  Powder for reconstitution for instillation
OncoTICE (Merck Sharp & Dohme (UK) Ltd) Hospital only
  aldesleukin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Proleukin (Clinigen Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  interferon gamma-1b Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Immukin (Clinigen Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  lenalidomide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA322
NICE TA171
NICE TA586
NICE TA587
NICE TA627
NICE TA680
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  mifamurtide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA235
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  pomalidomide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA427
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  talimogene laherparepvec [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA410
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  thalidomide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA228
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Malignant disease / Targeted therapy responsive malignancy
  abemaciclib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA563
NICE TA725
NICE TA810
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  acalabrutinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA689
NICE TA689
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  afatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA310
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  aflibercept [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA294
NICE TA305
NICE TA346
NICE TA409
NICE TA486
NICE TA307
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for injection
Eylea (Bayer Plc) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Zaltrap (Sanofi) Non-formulary at HHFT and not suitable for primary care prescribing
  alectinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA536
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  alpelisib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA816
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  asciminib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA813
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  avapritinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  axitinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA333
NICE TA645
NICE TA650
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  bortezomib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA370
NICE TA311
NICE TA228
NICE TA129
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for injection
Velcade (Janssen-Cilag Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  bosutinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA401
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  brigatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA571
NICE TA670
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Form unstated
Alunbrig (Takeda UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  cabozantinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA463
NICE TA542
NICE TA516
NICE TA928
NICE TA849
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Form unstated
Cometriq (Ipsen Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  carfilzomib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA657
NICE TA695
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for solution for infusion
Kyprolis (Amgen Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  ceritinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA395
NICE TA500
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  cobimetinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA414
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  crizotinib [Specialist drug] Hospital only NICE TA406
NICE TA422
NICE TA529
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  dabrafenib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA321
NICE TA396
NICE TA544
NICE TA898
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  dacomitinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA595
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  dasatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA426
NICE TA425
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  encorafenib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA562
NICE TA668
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  entrectinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA643
NICE TA644
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  erlotinib [Specialist drug] Hospital only NICE TA227
NICE TA258
NICE TA374
NICE TA374
Erlotinib is not approved for use at HUHFT for indications not recommended by NICE TA227 and TA374

NICE does not recommend this medicine for the following indications

TA227 - Erlotinib monotherapy is not recommended for maintenance treatment in patients with locally advanced or metastatic non-small-cell lung cancer who have stable disease after platinum-based first-line chemotherapy.

TA374 - Erlotinib is not recommended for treating locally advanced or metastatic non‑small‑cell lung cancer that has progressed after non‑targeted chemotherapy in patients with tumours that are EGFR‑TK mutation‑negative.

Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  everolimus Non-formulary at HHFT and not suitable for primary care prescribing NICE TA421
NICE TA432
NICE TA449
Afinitor® NICE TA498
Certican® NICE TA348
Certican® NICE TA481
  fedratinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA756
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  gefitinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA192
NICE TA374
NICE does not recommend this medicine for the following indication

TA374 - Gefitinib is not recommended for treating locally advanced or metastatic non‑small‑cell lung cancer that has progressed after non‑targeted chemotherapy in patients with tumours that are EGFR‑TK mutation‑positive.

 

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  gilteritinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA642
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  glasdegib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  ibrutinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA429
NICE TA891
NICE TA502
NICE TA795
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  idelalisib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA359
NICE TA604
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  imatinib [Specialist drug] Hospital only NICE TA326
NICE TA70
NICE TA86
NICE TA209
NICE TA426
NICE TA425
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Imatinib 600mg daily and 800mg daily doses are not approved for used as per NICE TA209 and TA425

NICE does not recommend the use of imatinib at 600mg daily and 800mg daily doses for the following indications

NICE TA209 - Imatinib 600 mg daily or 800 mg daily is not recommended for unresectable or metastatic, or both, gastro-intestinal stromal tumours whose disease has progressed after treatment with imatinib 400 mg daily.

NICE TA425 - High-dose imatinib (600 mg in the chronic phase or 800 mg in the accelerated and blast-crisis phases) is not recommended for treating Philadelphia-chromosome-positive CML in adults whose disease is imatinib-resistant.

  ixazomib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA870
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  lapatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA257
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  larotrectinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA630
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Oral solution
Vitrakvi (Bayer Plc) Non-formulary at HHFT and not suitable for primary care prescribing
  lenvatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA535
NICE TA551
NICE TA498
NICE TA858
NICE TA904
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  lorlatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA628
NICE TA909
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  midostaurin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA523
NICE TA728
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  mobocertinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA855
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  neratinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA612
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  nilotinib [Specialist drug] Hospital only NICE TA426
NICE TA425
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  nintedanib Non-formulary at HHFT and not suitable for primary care prescribing NICE TA347
NICE TA379
NICE TA864
NICE TA747
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  niraparib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA673
NICE TA784
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  olaparib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA598
NICE TA908
NICE TA946
NICE TA886
NICE TA887
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  osimertinib [Specialist drug] Hospital only NICE TA653
NICE TA654
NICE TA761
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  palbociclib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA495
NICE TA836
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  pazopanib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA215
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  pemigatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA722
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  ponatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA451
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  pralsetinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA812
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  regorafenib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA488
NICE TA555
NICE TA866
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  ribociclib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA496
NICE TA687
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  rucaparib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA611
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  ruxolitinib [Specialist drug] Hospital only NICE TA386
NICE TA921
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  selpercatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA742
NICE TA760
NICE TA911
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  sorafenib [Specialist drug] Hospital only NICE TA178
NICE TA474
NICE TA535
Sorafenib is approved for use at HUHFT only for the treatment of advanced hepatocellular carcinoma as per NICE TA474

NICE TA474 - Sorafenib is approved for use at HUHFT only for the treatment of advanced hepatocellular carcinoma.

NICE TA535 - Sorafenib is not approved for use at HUHFT for the treatment of differentiated thyroid cancer after radioactive iodine as the trust does not provide this service.

 

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  sotorasib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA781
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  sunitinib [Specialist drug] Hospital only NICE TA169
NICE TA179
NICE TA178
NICE TA449
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Sunitinib is approved for use at HUHFT only for the treatment of gastrointestinal stromal tumour (NICE TA179)

NICE TA179 - Sunitinib is approved for use at HUHFT only for the treatment of gastrointestinal stromal tumour. 

NICE TA169, TA178 and TA479 - Sunitinib is not approved for use at HUHFT for the treatment of the following conditions as the trust does not offer these services.

  • Advanced or metastatic renal cell carcinoma.
  • Unresectable or metastatic neuroendocrine tumours in people with progessive disease.

  temsirolimus [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA178
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for infusion
Torisel (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  tepotinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA789
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  tivozanib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA512
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  trametinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA396
NICE TA544
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  tucatinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA786
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  vandetanib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA550
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  vemurafenib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA269
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  venetoclax [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA561
NICE TA663
NICE TA796
NICE TA765
NICE TA787
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  vismodegib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA489
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  zanubrutinib [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA833
NICE TA931
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Malignant disease / Cytotoxic responsive malignancy
  amsacrine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Amsidine (Eurocept International bv) Non-formulary at HHFT and not suitable for primary care prescribing
  arsenic trioxide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA526
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Trisenox (Teva UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  asparaginase [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  azacitidine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA218
NICE TA399
NICE TA827
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for suspension for injection
Azacitidine (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Vidaza (Bristol-Myers Squibb Pharmaceuticals Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  bendamustine hydrochloride [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA216
NICE TA472
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  bexarotene [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  bleomycin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  busulfan [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  cabazitaxel [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA391
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  capecitabine [Specialist drug] Hospital only NICE TA263
NICE TA212
NICE TA191
NICE TA61
NICE TA100
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  carboplatin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA284
NICE TA285
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Carboplatin (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  carmustine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA121
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  chlorambucil [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA343
NICE TA344
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  chlormethine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA720
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  cisplatin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Cisplatin (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  cladribine Non-formulary at HHFT and not suitable for primary care prescribing NICE TA616
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Litak (Lipomed GmbH) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Leustat (Atnahs Pharma UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  clofarabine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Clofarabine (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  crisantaspase [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Erwinase (Porton Biopharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  cyclophosphamide Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Cyclophosphamide (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  cytarabine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Cytarabine (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  dacarbazine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Dacarbazine (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  daunorubicin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  daunorubicin with cytarabine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA552
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  decitabine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for solution for infusion
Dacogen (Janssen-Cilag Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  docetaxel [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA101
NICE TA509
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Docetaxel (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  doxorubicin hydrochloride [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA389
NICE TA465
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Doxorubicin hydrochloride (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Doxorubicin hydrochloride (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Caelyx (Baxter Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  epirubicin hydrochloride [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Epirubicin hydrochloride (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Pharmorubicin (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Epirubicin hydrochloride (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Pharmorubicin (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  eribulin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA423
NICE TA515
NICE TA515

The JPG agreed not to approve this medicine for treating locally advanced or metastatic breast cancer in adults who have had only 1 chemotherapy regimen as currently NICE cannot recommend its use.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Halaven (Eisai Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
NICE TA515

The JPG agreed not to approve this medicine for treating locally advanced or metastatic breast cancer in adults who have had only 1 chemotherapy regimen as currently NICE cannot recommend its use.

  estramustine phosphate [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  etoposide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Etopophos (Neon Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Etoposide (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  fludarabine phosphate [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA119
NICE TA29
NICE does not recommend this medicine for the following indication

TA29 - Fludarabine monotherapy is not recommended for the first-line treatment of chronic lymphocytic leukaemia.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Fludarabine phosphate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Fludarabine phosphate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Fludara (Sanofi) Non-formulary at HHFT and not suitable for primary care prescribing
  fluorouracil Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Fluorouracil (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Fluorouracil (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  gemcitabine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA25
NICE TA116
NICE TA285
NICE TA389
NICE TA476
NICE does not recommend this medicine for the following indications

TA285 - Bevacizumab in combination with gemcitabine and carboplatin is not recommended within its marketing authorisation, that is, for the treatment of the first recurrence of platinum-sensitive advanced ovarian cancer (including fallopian tube and primary peritoneal cancer) that has not been previously treated with bevacizumab or other vascular endothelial growth factor (VEGF) inhibitors or VEGF receptor-targeted agents.

TA389 - Gemcitabine, in combination with carboplatin, is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Gemcitabine (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  hydroxycarbamide Non-formulary at HHFT and not suitable for primary care prescribing
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  idarubicin hydrochloride [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  ifosfamide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Ifosfamide (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  irinotecan hydrochloride [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA440
NICE does not recommend this medicine for the following indication

TA440 - Pegylated liposomal irinotecan, in combination with fluorouracil and leucovorin, is not recommended for treating metastatic adenocarcinoma of the pancreas in adults whose disease has progressed after gemcitabine-based therapy.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Irinotecan hydrochloride (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Campto (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  lomustine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  melphalan [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder and solvent for solution for injection
Melphalan (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  mercaptopurine Non-formulary at HHFT and not suitable for primary care prescribing
  methotrexate Non-formulary at HHFT and not suitable for primary care prescribing
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Oral solution
Methotrexate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Methotrexate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Metoject PEN (medac UK) Non-formulary at HHFT and not suitable for primary care prescribing
Nordimet (Nordic Pharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Zlatal (Nordic Pharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Methotrexate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  mitomycin [Specialist drug] Hospital only
  Powder for solution for injection
Mitomycin (Non-proprietary) Hospital only
  mitotane [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  mitoxantrone [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Onkotrone (Baxter Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  nelarabine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Atriance (Sandoz Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  oxaliplatin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA100
NICE TA93
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Oxaliplatin (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  paclitaxel [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA55
NICE TA284
NICE TA389
NICE TA476
NICE does not recommend this medicine for the following indications

TA108 - Paclitaxel, within its licensed indication, is not recommended for the adjuvant treatment of women with early node-positive breast cancer.

TA284 - Bevacizumab in combination with paclitaxel and carboplatin is not recommended for the first-line treatment of advanced ovarian cancer (including fallopian tube and primary peritoneal cancer).

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Paclitaxel (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  panobinostat [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA380
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  pegaspargase [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA408
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  pemetrexed [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA124
NICE TA181
NICE TA402
NICE TA190
NICE TA135
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Powder for solution for infusion
Pemetrexed (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Alimta (Eli Lilly and Company Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  pentostatin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Nipent (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  pixantrone [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA306
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  procarbazine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  raltitrexed [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  tegafur with gimeracil and oteracil [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  temozolomide [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA23
NICE TA121
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  thiotepa [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  tioguanine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  topotecan [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA183
NICE TA184
NICE TA389
NICE does not recommend this medicine for the following indication

TA389 - Topotecan is not recommended for treating first recurrence of platinum‑sensitive ovarian cancer, recurrent platinum‑resistant ovarian cancer, or platinum‑refractory ovarian cancer.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Topotecan (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  trabectedin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA185
NICE TA389
NICE does not recommend this medicine for the following indication

TA389 - Trabectedin in combination with pegylated liposomal doxorubicin hydrochloride (PLDH) is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer.

Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for infusion
Yondelis (Immedica Pharma AB) Non-formulary at HHFT and not suitable for primary care prescribing
  treosulfan [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA640
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder for solution for injection
Treosulfan (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  tretinoin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  trifluridine with tipiracil [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing NICE TA405
NICE TA852
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  vinblastine sulfate [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Vinblastine sulfate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  vincristine sulfate [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Vincristine sulfate (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  vindesine sulfate [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Eldisine (Genus Pharmaceuticals Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  vinorelbine [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Vinorelbine (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Navelbine (Pierre Fabre Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Malignant disease / Cytotoxic drug-induced side effects
  dexrazoxane Non-formulary at HHFT and not suitable for primary care prescribing
  Powder and solvent for solution for infusion
Savene (Clinigen Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  folinic acid Hospital only NICE TA212
  Solution for injection
Folinic acid (Non-proprietary) Hospital only
Sodiofolin (medac UK) Hospital only
  levofolinic acid Not approved for prescribing
  Solution for injection
Isovorin (Pfizer Ltd) Not approved for prescribing
  mesna Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Mesna (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Malignant disease / Hyperuricaemia associated with cytotoxic drugs
  allopurinol Non-formulary at HHFT and not suitable for primary care prescribing
  febuxostat Non-formulary at HHFT and not suitable for primary care prescribing NICE TA164
  rasburicase Hospital only
  Powder and solvent for solution for infusion
Fasturtec (Sanofi) Hospital only
Malignant disease / Hormone responsive malignancy
  abiraterone acetate Hospital only NICE TA259
NICE TA387
NICE TA721
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  apalutamide Hospital only NICE TA740
NICE TA741
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  bicalutamide Specialist knowledge/initiation
  buserelin Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Suprecur (Neon Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Suprefact (Neon Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Spray
Suprecur (Neon Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  cyproterone acetate Specialist knowledge/initiation
  darolutamide Non-formulary at HHFT and not suitable for primary care prescribing NICE TA660
NICE TA903
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  degarelix Hospital only NICE TA404
  Powder and solvent for solution for injection
Firmagon (Ferring Pharmaceuticals Ltd) Hospital only
  diethylstilbestrol Specialist knowledge/initiation
  enzalutamide Hospital only NICE TA316
NICE TA377
NICE TA580
NICE TA712
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  ethinylestradiol Not approved for prescribing
  flutamide Specialist knowledge/initiation
  goserelin Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  lanreotide Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Somatuline Autogel (Ipsen Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  leuprorelin acetate Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Powder and solvent for suspension for injection
Prostap 3 DCS (Takeda UK Ltd) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

Prostap SR DCS (Takeda UK Ltd) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  medroxyprogesterone acetate Non-formulary at HHFT and not suitable for primary care prescribing
  megestrol acetate Specialist knowledge/initiation
  Oral suspension
Megestrol acetate (Non-proprietary) Specialist knowledge/initiation
  norethisterone Non-formulary at HHFT and not suitable for primary care prescribing
  octreotide Hospital only
Agreement between the GP and the hospital

This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.

  Solution for injection
Octreotide (Non-proprietary) Hospital only
Agreement between the GP and the hospital

This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.

Sandostatin (Novartis Pharmaceuticals UK Ltd) Hospital only
Agreement between the GP and the hospital

This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.

  Powder and solvent for suspension for injection
Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) Hospital only
Agreement between the GP and the hospital

This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.

  pasireotide Not approved for prescribing
  Solution for injection
Signifor (Recordati Rare Diseases UK Ltd) Not approved for prescribing
  triptorelin Shared care guideline
  Powder and solvent for suspension for injection
Decapeptyl SR (Ipsen Ltd) Shared care guideline
Gonapeptyl Depot (Ferring Pharmaceuticals Ltd) Shared care guideline
Salvacyl (Ipsen Ltd) Shared care guideline
Malignant disease / Hormone responsive breast cancer
  anastrozole Specialist knowledge/initiation
  exemestane Specialist knowledge/initiation
  fulvestrant Non-formulary at HHFT and not suitable for primary care prescribing NICE TA503
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for injection
Fulvestrant (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Faslodex (AstraZeneca UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  letrozole Specialist knowledge/initiation
  tamoxifen Specialist knowledge/initiation
  Oral solution
Tamoxifen (Non-proprietary) Specialist knowledge/initiation
  toremifene Hospital only
Malignant disease / Photodynamic therapy responsive malignancy
  porfimer sodium [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  temoporfin [Specialist drug] Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Foscan (Biolitec Pharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Malignant disease / Secondary bone metastases and hypercalcaemia
  calcitonin (salmon) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for injection
Calcitonin (salmon) (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  denosumab Hospital only NICE TA204
NICE TA265
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for injection
Xgeva (Amgen Ltd) Hospital only
  ibandronic acid Non-formulary at HHFT and not suitable for primary care prescribing NICE TA464
Mixed formulary statuses

The JPG agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided that it is used specifically in accordance with NICE Technology Appraisal(s).

Specialist knowledge/initiation - Ibandronic acid tablets 150mg for the treatment of osteoporosis in adults

Hospital only - Ibandronic acid 3mg solution for injection for the treatment of osteoporosis in adults

Non-formulary at HUHFT. Hospital only for providers that have this on their formulary - Ibandronic acid is not approved for secondary bone metastases and hypercalcaemia

 

  Solution for infusion
Ibandronic acid (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Bondronat (Atnahs Pharma UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  pamidronate disodium Hospital only
  Solution for infusion
Pamidronate disodium (Non-proprietary) Hospital only
  sodium clodronate Non-formulary at HHFT and not suitable for primary care prescribing
  zoledronic acid Hospital only NICE TA464
  Infusion
Zometa (Phoenix Labs Ltd) Hospital only
  Solution for infusion
Zoledronic acid (Non-proprietary) Hospital only
Zometa (Phoenix Labs Ltd) Hospital only